The transplant monitoring kit market is estimated to secure a valuation of US$ 5.2 Billion in 2023 and is estimated to rise to US$ 8.2 billion by 2033. The market is anticipated at a CAGR of 4.6% during the forecast period. The factors accelerating the demand for transplant monitoring kits are as follows-
The increasing number of organ failures is expected to lead to a growing number of organ transplant surgeries performed globally. The global transplant monitoring kit market is expected to grow at a rapid pace during the forecast period.
Over the forecast period, the transplant monitoring kits market is expected to be influenced by government initiatives for promoting people for organ donation.
Other significant factors influencing the growth of the transplant monitoring kit market are increased use of personalized medicines, increased number of stem cell therapies, and tissue transplants, and increased government funding in the healthcare system. Owing to the above-mentioned factors the sales of transplant monitoring kits are expected to increase during the forecast period.
North America is expected to lead the market for transplant monitoring kits during the forecast period owing to the increased number of transplants performed in the USA and Canada. Also, technological advances in healthcare provide opportunities for market development.
Europe accounts for the second-highest share of the global transplant monitoring kits market. The increasing advances in transplant procedures and the presence of skilled medical professionals in the region drive market growth.
Asia Pacific is expected to be the fastest-growing region in the transplant monitoring kits market and is projected to grow in near future owing to the developing healthcare sector and the high adoption of innovative transplant monitoring kits by medical professionals. Also, the growing R&D activities in healthcare and the increased number of organ transplants performed in the region drive market growth.
| Data Point | Key statistics |
|---|---|
| Expected Market Value in 2023 | US$ 5.2 Billion |
| Projected Market Value in 2033 | US$ 8.2 Billion |
| Growth Rate (2023 to 2033) | CAGR of 4.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
CareDx Inc, Thermo Fisher Scientific, QUIGEN, Hologin Inc, Eurofins Scientific, JETA Molecular BV, ELITech Group SAS, NateraInc, F.Hoffman La Roche Ltd, Biocare Health Resources Inc, BioRad Laboratories Inc, Genome Diagnostics B.V, and SanBio BV, are some of the leading market players operating in transplant monitoring kits market.
The serval companies operating in transplant monitoring kits market are implementing various strategies and focusing on new product launches, product approvals and development to increase the sales globally
The transplant monitoring kits market is expected to grow in the coming years. The increasing demand for effective transplant monitoring kits and an increasing number of clinical procedures are expected to drive market growth during the forecast period. Several start-ups have entered the transplant monitoring kit market with innovative products with the use of new technology.
The Transplant Monitoring Kits will show growth due to the rising organ transplants globally and an increased number of donors to support the recipients’ transplantation. Therefore, growth at a significantly high CAGR will be expected soon.
The rising transplants globally are giving a major driving factor for the requirement of transplant monitoring kits. Among transplant recipients, non-adherence to immunosuppressive medications is a major cause of antibody-mediated rejection, which leads to graft loss.
Immunosuppressant non-adherence also contributes to the increased healthcare costs associated with acute rejection treatment, additional hospitalization, and kidney transplantation re-dialysis. Therefore, it is crucial to monitor post-transplantation who require long-term pharmacotherapy and prevent non-adherence.
Previous studies have reported that approximately 14–36% of kidney transplant recipients are non-adherent to immunosuppressive medications. The immune system is inclined to attack foreign organisms introduced to the body, and the body interprets a new organ as foreign.
Also, there has been significant growth in stem cell transplants for treating chronic diseases which will drive the market.
Principal Consultant
According to a study, end-stage organ failure is estimated to affect more than six million people worldwide. Advancements in surgical techniques, immunosuppression, donor-recipient matching, and antimicrobial agents have all contributed to increasing patient success during transplant procedures.
Close monitoring of patients is essential after a transplant to ensure the body is not rejecting its new organ. The transplant patients usually receive therapeutic drugs post-transplant to help their bodies accept the new organ and remain healthy.
These therapeutic drugs require monitoring to make sure the patient is receiving the correct dosage for the greatest benefit without negative side effects or complications. As transplantation is the most favourable therapy for end-stage disease, the risk of rejection remains a constant concern.
Allograft rejection leads to a high risk of graft dysfunction, accompanied by a significantly higher probability of chronic failure and graft loss. This causes re-hospitalization and prolonged therapy or maybe death. Therefore it’s important to monitor the post-transplant.
USA and Canada will retain the top position in the market of Transplant Monitoring Kits due to the larger number of transplants taking in the region. According to the United Network for Organ Sharing, in 2019 in the USA 39,717 organ transplants were executed. This number is continuously rising as there has been an increase in live donor transplants.
According to Organ Procurement and Transplantation Network, there were a total of 5,725 living donor transplants were performed in 2020, a decrease of 22.6 percent over the record of 7,397 set in 2019 due to the COVID-19 outbreak.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Europe is seeing growth in advancement in the healthcare sector and an increase in demand for better healthcare providing opportunities will lead the transplant monitoring kits market in Europe.
According to EDQM and the Council of Europe, there were 34,221 organ transplants in Europe in 2018. There has been observance of increasing organ donors in the region making it possible for more transplants in the future.
This will result in developing the Transplant Monitoring Kits demand in Europe during the forecast period. Also, the support of the government for the treatment of chronic diseases and surgeries will lead to the adoption of transplants in the forecasted period.
Some of the leading manufacturers and suppliers of Transplant Monitoring Kits include
These companies followed certain strategies like partnership, collaboration, product launch, and mergers and acquisitions to gain a good position in the market. For instance, in June 2019, Eurofins Scientific acquired Transplant Genomics Inc., to improve the product line for improving organ transplant outcomes.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Technology Type 6.2. Product 6.3. Application 6.4. Transplant Type 6.5. End User 7. Global Market Analysis and Forecast, By Technology Type 7.1. Molecular Assay Technologies 7.2. PCR-Based Molecular Assays 7.3. Real-time PCR 7.4. Sequence-specific Primer-PCR 7.5. Sequence-specific Oligonucleotide-PCR 7.6. Other PCR-based Molecular Assays 7.7. Sequencing-based Molecular Assays 7.8. Sanger Sequencing 7.9. Next-generation Sequencing 7.10. Other Sequencing-based Molecular Assays 8. Global Market Analysis and Forecast, By Product 8.1. Reagents & Consumables 8.2. Instruments 8.3. Software & Services 9. Global Market Analysis and Forecast, By Application 9.1. Diagnostic Applications 9.2. Pre-transplantation Diagnostics 9.3. Infectious Disease Testing 9.4. Histocompatibility Testing 9.5. Blood Profiling 9.6. Post-transplantation Diagnostics 9.7. Research Applications 10. Global Market Analysis and Forecast, By Transplant Type 10.1. Solid Organ 10.2. Stem Cell 10.3. Soft Tissue 11. Global Market Analysis and Forecast, By End User 11.1. Independent Reference Laboratories 11.2. Hospitals & Transplant Centres 11.3. Research Laboratories & Academic Institutes 12. Global Market Analysis and Forecast, By Region 12.1. North America 12.2. Latin America 12.3. Western Europe 12.4. Eastern Europe 12.5. Asia Pacific 12.6. East Asia 12.7. MEA 13. North America Sales Analysis and Forecast, by Key Segments and Countries 14. Latin America Sales Analysis and Forecast, by Key Segments and Countries 15. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 16. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 17. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries 18. East Asia Sales Analysis and Forecast, by Key Segments and Countries 19. MEA Sales Analysis and Forecast, by Key Segments and Countries 20. Sales Forecast by Technology Type, Product, Application, Transplant Type, and End User for 30 Countries 21. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 22. Company Profile 22.1. Thermo Fisher Scientific 22.2. QIAGEN 22.3. Hologic Inc. 22.4. Eurofins Scientific 22.5. JETA Molecular BV. 22.6. ELITech Group SAS 22.7. Natera Inc. 22.8. F. Hoffmann-La Roche Ltd 22.9. Biocare Health Resources Inc. 22.10. Bio-Rad Laboratories Inc. 22.11. Biogenuix Medsystems Pvt Ltd 22.12. Genome Diagnostics B.V. 22.13. Sanbio B.V.
Explore Healthcare Insights
View Reports
Transplant Monitoring Kits Market
